- Medical Management of Patients With Heart Failure and Reduced Ejection Fraction
-
Greenberg B
- KMID: 2526959
- Korean Circ J.
- 2022 Mar;52(3):173-197.
- doi: 10.4070/kcj.2021.0401
Treatment options for patients with heart failure (HF) with reduced ejection fraction (HFrEF) have expanded considerably over the past few decades. Whereas neurohormonal modulation remains central to the management of... -
- CITED
-
- Close
- SHARE
-
- Close
- Angiotensin Receptor-Neprilysin Inhibition (ARNI) in Heart Failure
-
Greenberg B
- KMID: 2532619
- Int J Heart Fail.
- 2020 Apr;2(2):73-90.
- doi: 10.36628/ijhf.2020.0002
Recognition that neurohormonal activation plays a central role in the pathogenesis of heart failure (HF) led to the development of angiotensin converting enzyme inhibitors (ACEIs), angiotensin receptor blockers, mineralocorticoid receptor... -
- CITED
-
- Close
- SHARE
-
- Close
